Stocks
Health Care
vrca
Verrica Pharmaceuticals
NASDAQ: VRCA
+2.29 (+34.13%)
9
USD
At close at Nov 28, 21:42 UTC
Income Statement
Revenue
7.57M
Gross Profit
4.83M
Operating Income
-65.92M
Pretax Income
-48.60M
Net Income
-76.58M
EBITDA
-65.90M
EBIT
-67.17M
Earnings Per Share
-14.800000000000002
Balance Sheet
Cash & Cash Equivalents
37.54M
Total Debt
46.45M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-13.93M
Book Value Per Share
-3.22
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.